The pharmaceutical industry has experienced a groundbreaking advancement in diabetes management with the arrival of copyright. This transformative medication, categorized as a glucagon-like peptide-1 (GLP-1) receptor agonist, offers a novel approach to regulating blood sugar levels in individuals wi